List of Tables
Table 1. Crohn’s Disease Therapeutics Market Trends
Table 2. Crohn’s Disease Therapeutics Market Drivers & Opportunity
Table 3. Crohn’s Disease Therapeutics Market Challenges
Table 4. Crohn’s Disease Therapeutics Market Restraints
Table 5. Global Crohn’s Disease Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Crohn’s Disease Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Crohn’s Disease Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Crohn’s Disease Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Crohn’s Disease Therapeutics
Table 10. Global Crohn’s Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Crohn’s Disease Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Crohn’s Disease Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Crohn’s Disease Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Crohn’s Disease Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Crohn’s Disease Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Crohn’s Disease Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Crohn’s Disease Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Crohn’s Disease Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Crohn’s Disease Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Crohn’s Disease Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Crohn’s Disease Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Crohn’s Disease Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Crohn’s Disease Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Crohn’s Disease Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Crohn’s Disease Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Crohn’s Disease Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Crohn’s Disease Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Crohn’s Disease Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Johnson and Johnson Services Inc. Basic Information List
Table 32. Johnson and Johnson Services Inc. Description and Business Overview
Table 33. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Johnson and Johnson Services Inc. (2019-2024)
Table 35. Johnson and Johnson Services Inc. Recent Developments
Table 36. Pfizer Inc. Basic Information List
Table 37. Pfizer Inc. Description and Business Overview
Table 38. Pfizer Inc. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Pfizer Inc. (2019-2024)
Table 40. Pfizer Inc. Recent Developments
Table 41. Allergan Basic Information List
Table 42. Allergan Description and Business Overview
Table 43. Allergan Crohn’s Disease Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Allergan (2019-2024)
Table 45. Allergan Recent Developments
Table 46. AbbVie Inc. Basic Information List
Table 47. AbbVie Inc. Description and Business Overview
Table 48. AbbVie Inc. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of AbbVie Inc. (2019-2024)
Table 50. AbbVie Inc. Recent Developments
Table 51. Takeda Pharmaceutical Company Limited Basic Information List
Table 52. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 53. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Takeda Pharmaceutical Company Limited (2019-2024)
Table 55. Takeda Pharmaceutical Company Limited Recent Developments
Table 56. Celgene Corporation Basic Information List
Table 57. Celgene Corporation Description and Business Overview
Table 58. Celgene Corporation Crohn’s Disease Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Celgene Corporation (2019-2024)
Table 60. Celgene Corporation Recent Developments
Table 61. Perrigo Company PLC Basic Information List
Table 62. Perrigo Company PLC Description and Business Overview
Table 63. Perrigo Company PLC Crohn’s Disease Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Perrigo Company PLC (2019-2024)
Table 65. Perrigo Company PLC Recent Developments
Table 66. Ferring B.V. Basic Information List
Table 67. Ferring B.V. Description and Business Overview
Table 68. Ferring B.V. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Ferring B.V. (2019-2024)
Table 70. Ferring B.V. Recent Developments
Table 71. Salix Pharmaceuticals Basic Information List
Table 72. Salix Pharmaceuticals Description and Business Overview
Table 73. Salix Pharmaceuticals Crohn’s Disease Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Salix Pharmaceuticals (2019-2024)
Table 75. Salix Pharmaceuticals Recent Developments
Table 76. Gilead Sciences Inc. Basic Information List
Table 77. Gilead Sciences Inc. Description and Business Overview
Table 78. Gilead Sciences Inc. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Gilead Sciences Inc. (2019-2024)
Table 80. Gilead Sciences Inc. Recent Developments
Table 81. Genentech Inc. Basic Information List
Table 82. Genentech Inc. Description and Business Overview
Table 83. Genentech Inc. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of Genentech Inc. (2019-2024)
Table 85. Genentech Inc. Recent Developments
Table 86. UCB India Private Limited. Basic Information List
Table 87. UCB India Private Limited. Description and Business Overview
Table 88. UCB India Private Limited. Crohn’s Disease Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Crohn’s Disease Therapeutics Business of UCB India Private Limited. (2019-2024)
Table 90. UCB India Private Limited. Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Crohn’s Disease Therapeutics Downstream Customers
Table 94. Crohn’s Disease Therapeutics Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Crohn’s Disease Therapeutics Product Picture
Figure 2. Global Crohn’s Disease Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Crohn’s Disease Therapeutics Report Years Considered
Figure 5. Global Crohn’s Disease Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Crohn’s Disease Therapeutics Revenue in 2023
Figure 7. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Non-Surgical Picture
Figure 9. Surgical Picture
Figure 10. Global Crohn’s Disease Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Crohn’s Disease Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Ambulatory Surgical Centers
Figure 14. Global Crohn’s Disease Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Crohn’s Disease Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 17. North America Crohn’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe Crohn’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific Crohn’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 22. South America Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. South America Crohn’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa Crohn’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa Crohn’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions Crohn’s Disease Therapeutics Sales Value (%), (2019-2030)
Figure 27. United States Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 29. United States Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. China Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. China Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. China Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. India Crohn’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. India Crohn’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. India Crohn’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. Crohn’s Disease Therapeutics Industrial Chain
Figure 49. Crohn’s Disease Therapeutics Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
